Please click on the logo to access the Final WCPD2021 Programme
WCPD2021 FINAL PROGRAMMEv3 click to download a PDF version of the flipbook above
Sessions & Speakers
Dr Andrea Zaenglein (Pennsylvania, USA)
Hormonal Treatment of Acne in Adolescents
Dr. Zaenglein is a Professor of Dermatology and Pediatrics at the Pennsylvania State University College of Medicine/ Hershey Medical Center in Hershey, Pennsylvania.
In her academic career, Dr. Zaenglein has overseen numerous clinical trials in children and young adults. Her particular areas of research interest are acne and novel therapies for pediatric skin diseases.
Dr. Zaenglein is involved with a number of professional organizations, including the Society for Pediatric Dermatology, the Pediatric Dermatology Research Alliance (PeDRA), the American Academy of Dermatology, the American Acne and Rosacea Society and the International Society for the Study of Vascular Anomalies. She currently serves as Co-Editor in Chief of the journal, Pediatric Dermatology, is Past President of the Society for Pediatric Dermatology, and Chair of the PeDRA Acne and HS Focused Study Group, President Elect of the American Acne and Rosacea Society.
Dr Brenda Kelly (Oxford, UK)
Female Genital Mutilation
Dr Brenda Kelly is a consultant obstetrician in Oxford with a longstanding interest in migrant women’s health. She is founder and director of the Oxford Rose Clinic- a specialist service providing holistic care and support for women and girls with female genital mutilation (FGM).
Dr Lucía Campos-Muñoz (Madrid, Spain)
Management of transgender adolescent skin
Dr Lucía Campos –Muñoz is a dermatologist and paediatric dermatologist working as consultant of Dermatology Service in Hospital Clínico San Carlos (Madrid). She works mainly in the paediatric and adolescent dermatology area. In recent years, she has had occasion to treat and study numerous adolescent transgender patients, focusing on the dermatological impact of hormone therapy; she has also published several articles related to this topic.
She is Associate Professor at the Complutense University of Madrid (Medicine School).
Dr Campos is a board member os the Spanish Group of Paediatric Dermatology.
Dr Tess McPherson (Oxford, UK)
Skin Stigma and Services
Dr Tess McPherson MA MBBS MD FRCP is Consultant Dermatologist, Senior Clinical Lecturer & Clinical Lead for Paediatric and Adolescent Dermatology at Oxford University Hospitals. She is active in national and international paediatric dermatology including developing clinical guidelines and patient information for the British Association of Dermatology (BAD) monitoring effects of medications on children and young people (BADBIR registry) and is the President-Elect of the British Society of Paediatric Dermatology (BSPD).
Skin conditions are very common and have huge impact for young people but their needs are often overlooked. Through her clinical work and national roles with BAD and the BSPD team, Dr McPherson is committed to providing better services and support for this vulnerable population. In Oxford she has established an award-winning service for young people with skin conditions that integrates psychological support. This model is now being established in other centres. The BSPD website also now has a dedicated section with information for both health professionals working with adolescents and information for young people themselves.
Dr McPherson was lead clinician on an NIHR funded project to develop a web resource for young adults with skin disease on healthtalk.org, works with charities and patient groups to improve resources and has recently written a book; ‘Skin Conditions in Young People: A practical guide on how to be comfortable in your skin’.
We are delighted to be running a dedicated session on adolescent skin at the WCPD and hope you enjoy, contribute and take something from this to help you support the young people you work with.
Dr Michael Farquhar (London, UK)
Sleep in adolescents
Mike Farquhar has been a consultant in sleep medicine at Evelina London Children’s Hospital since 2012, having trained in Glasgow, Nottingham, Sydney and London.
Evelina London provides comprehensive assessment and management across the whole spectrum of paediatric sleep disorders, including the largest group of children with narcolepsy in the UK.
Mike and colleagues worked with the PSHE Association to include teaching about sleep in the English school curriculum, emphasising the importance of children, young people, and families learning to prioritise sleep.
Mike works to improve education of healthcare staff about sleep, and the impact of sleep deprivation/fatigue on the ability to provide 24/7 NHS care. He has been awarded the Association Award of the Association of Anaesthetists of Great Britain and Ireland, and the Royal College of Anaesthetists Humphry Davy Award, for his contributions to the #FightFatigue campaign.
Mike also works to raise awareness of issues and challenges faced by LGBT+ young people, particularly when accessing NHS care. He was a lead developer of the Rainbow NHS Badge project, which is now spreading across the NHS.
Mike is on Twitter @DrMikeFarquhar.
Jodi Whitehouse (Liverpool, UK)
Public Exhibition of Naevi Improves Self-Image
Jodi Whitehouse is the founder and Chief Executive of Caring Matters Now, the UK charity supporting those affected by Congenital Melanocytic Naevus (CMN). Caring Matters Now aims to support children and adults affected by CMN, raise global awareness of CMN and raise funds for CMN research.
Prof Maurice van Steensel (Singapore)
Acne – Pathogenesis Based Treatment
Dr Antoni Gostynski (Maastricht, The Netherlands)
Therapy for Conradi-Hunnermann
Dr Lea Solman (London, UK)
Management of non-IH vascular tumours
Dr James Treat (Philadelphia, USA)
Re-purposing of Therapies in Paediatric Dermatology
Dr. Treat is Professor of Clinical Pediatrics and Dermatology at the Perelman School of Medicine at the University of Pennsylvania with his main clinical appointment at the Children‘s Hospital of Philadelphia. He is the education and fellowship director of Pediatric Dermatology. Dr. Treat is an author on Andrews Diseases of the skin and has given hundreds of invited lectures nationally and internationally. He directs the dermatology course for the Perelman school of medicine and has won 19 teaching awards including the 2016 Provost award for excellence in teaching at the University of Pennsylvania, the 2013 Master Clinician Award at the Children’s Hospital of Philadelphia and was elected to the Academy of Master Clinicians at the University of Pennsylvania in 2020.
Dr Karolina Gholam (London, UK)
Biologics in Psoriasis
Dr Mark Koh (Singapore)
Adverse Drug Reactions in Paediatric Dermatology
Dr. Mark Koh is a dermatologist, paediatric dermatologist and dermatopathologist. He is head and senior consultant of Dermatology Service, KK Women’s & Children’s Hospital, as well as visiting consultant at Singapore General Hospital, Sengkang General Hospital & National Cancer Centre. His sub-specialty interests in paediatric dermatology include atopic dermatitis, genodermatoses, vascular anomalies and histiocytic disorders. His other sub-specialty interests include cutaneous lymphoma and skin cancer syndromes. Dr. Koh is an Associate Professor at the Duke-NUS Graduate Medical School and Adjunct Associate Professor at the Nanyang Technological University Lee Kong Chian School of Medicine. He is also a senior clinical lecturer at the National University of Singapore Yong Loo Lin Medical School. Dr. Koh is Secretary General of the Asian Society of Pediatric Dermatology (ASPD) and a Board Member of the International Society of Pediatric Dermatology (ISPD).
Allergy, Contact Dermatitis & Urticaria
SESSION CHAIRS: DR CARINA VENTER & DR NATALIA CARTLEDGE
SESSION SPEAKERS:
Dr Tabi Leslie (London, UK)
Novel Therapies Urticaria
Dr Tabi Leslie is a Consultant Dermatologist at the Royal Free Hospital, London, where she runs a specialist urticaria service. Her academic and clinical interests include urticaria, angioedema, mastocytosis and itch.
Dr Leslie is the Honorary Secretary at the British Association of Dermatologists (BAD). She has been on the Council of the Royal Society of Medicine (RSM) Dermatology Section and was a past Secretary of the Section. She is also the past President of the RSM Clinical Immunology and Allergy (CIA) section. Dr Leslie has been an elected Dermatology Board member for the European Academy of Allergy and Clinical Immunology (EAACI) and is Secretary of the EAACI Chronic Urticaria in Children (CU-Kids) Task Force. Dr Leslie is involved in the European and British guidelines for urticaria and for pruritus. She has published widely and has been an invited author for Rook’s Textbook of Dermatology and Treatment of Skin Disease: Comprehensive Therapeutic Strategies.
Prof Adam Fox (London, UK)
The Future of Food Allergy Management
Adam read Medicine and Neuroscience at Cambridge University before completing his clinical training at University College, London. After specialist training in Paediatric Allergy in 2006, he spent 9 years as clinical lead for Allergy (Adult & Paediatric) at Guy’s & St Thomas’ Hospitals, London – one of Europe’s largest specialist Allergy services, recognised as an International Centre of Excellence by both the World Allergy Organisation and GALEN (European Asthma & Allergy Network). After 3 years as Clinical Director for Specialist Ambulatory Medicine, he took up the post of Deputy Medical Director (Commercial) for Guy’s & St Thomas’ Hospitals NHS Foundation Trust in 2018. He is also a Professor of Paediatric Allergy at King’s College London and the founding Director of the KCL Allergy Academy, a postgraduate educational programme, which was a finalist at the BMJ Awards in 2018.
Adam chaired the UK Department of Health National Care Pathway for Food Allergy in Childhood and was a member of the National Institute of Healthcare and Clinical Excellence (NICE) clinical guideline development group for the assessment and diagnosis of food allergy in children. He previously chaired the Paediatric Committee of the British Society of Allergy & Clinical Immunology and was elected as President, the first Paediatrician to hold this position, from October 2018.
Adam was awarded ‘Paediatric Allergist of the Year’ from Allergy UK in 2007. His doctoral thesis on peanut allergy received the Raymond Horton Smith prize from Cambridge University in 2012 and he was included in The Times ‘Britain’s 100 Best Children’s Doctor’s’ (2012). Adam received the William Frankland Award for Outstanding contribution to Allergy from the British Society of Allergy & Clinical Immunology in 2015 and a National Clinical Excellence award from the UK Department of Health in 2016 and 2020.
@dradamfox
Declarations of interest can be found at http://www.whopaysthisdoctor.org/doctor/511 .
Prof Antti Lauerma (Helsinki, Finland)
Allergic contact dermatitis: New emerging allergens
Prof Carina Venter (Colorado, USA)
Elimination diets for eczema: benefits and risks
Dr. Venter (PhD RD) is an Allergy Specialist Dietititan and Associate Professor of Pediatrics, Section of Allergy/Immunology at the Children’s Hospital Colorado and University of Colorado Denver, where she is conducting research in allergy prevention and working with children with food allergies. She is a member of American, European, and British Allergy Societies. She moved from the UK in 2015 where she performed research into food allergy prevalence funded by the Food Standards Agency, UK. She is a member of European and American food allergy guidelines on Allergy Prevention. She was also a member of the NICE (UK) and National Institutes for Allergy and Infectious Diseases Food Allergy guidelines. She is active on twitter with over 4000 followers and her twitter handle is @VenterCarina
Dr Diana Purvis (Auckland, New Zealand)
The classification of topical corticosteroids: chaos in need of harmony
Diana Purvis is dual-trained in paediatrics and dermatology, training in New Zealand and the United Kingdom. She is the head of Paediatric Dermatology at New Zealand’s national tertiary paediatric centre, Starship Children’s Hospital in Auckland, providing care for children around New Zealand and the South Pacific.
Diana is a senior lecturer at the University of Auckland, is deputy chair of the Advanced Training Committee for dermatology in NZ, sits on the Dermatology Subcommittee of Pharmac (NZ pharmaceutical agency), and is the former lead of the New Zealand Eczema Clinical Network. She has a wide range of interests including eczema, ichthyoses, epidermolysis bullosa, and vascular anomalies. She has been the visiting dermatologist to the Cook Islands since 2015.
Dr Natalie Cartledge (London, UK)
Prevention of food allergy through skin care in infancy
Dr Natalia Cartledge is a paediatrician working in paediatric dermatology at Great Ormond Street Hospital providing holistic patient centred care to children and young people with skin problems. She is also the lead for paediatric dermatology and allergy at Royal Surrey Foundation Trust where she established the dermatology service for children and young people. Her areas of expertise include atopic diseases, eczema and birth marks. She is an innovative dynamic consultant developing efficient front line services providing best care for children and young people. She has a passion for medical education and she regularly teaches medical students, junior doctors, nurses and primary care physicians
Prof Carsten Flohr (London, UK)
Systemic treatments
Carsten Flohr studied at Cambridge and Oxford Universities and then trained in both paediatrics and dermatology.
He was the first UK National Institute for Health Research (NIHR) Clinician Scientist in Dermatology (2009-2014) and the only dermatologist who held a Career Development Fellowship from the NIHR (2014-2019).
Professor Flohr directs the Unit for Population-Based Dermatology Research at St John’s Institute of Dermatology, King’s College London, where he holds the Chair in Dermatology and Population Health Science.
He has a particular interest in novel methods of atopic dermatitis (AD) prevention (early life risk factors) and therapeutics, especially in severe AD.
He is Chief Investigator of the UK-Irish TREatment of severe eczema in children Trial (TREAT), which compares cyclosporine with methotrexate in children with recalcitrant atopic eczema. He is also Chief Investigator of the Softened water for eczema prevention trial (SOFTER) and the UK-Irish Atopic Eczema Systemic Therapy Register (A-STAR).
Prof Flohr is a Founding Director of the International Eczema Council and President of the British Society of Paediatric Dermatology.
He is Founding Editor of the Evidence-Based Dermatology Section of the British Journal of Dermatology and the Clinical Trials Editor of the F1000 Atopic Dermatitis Section.
Prof Stephanie Christen-Zäch (Lausanne, Switzerland)
The role of the microbiome in AD
Head of Pediatric Dermatology Unit
Departments of Pediatrics and Dermatology
Children’s Hospital Lausanne University
Centre Hospitalier Universitaire Vaudois
Switzerland
Stephanie Christen-Zäch is privat docent and head of the pediatric dermatology unit in the departments of dermatology and pediatrics at the University Hospital Lausanne. She received her medical degree from Basel University, followed by a residency in dermatology and venereology at the University of Basel and Lausanne. She is a board certified dermatologist and performed a fellowship in dermatopathology at the Harvard Medical School with Philippe McKee. For three years she was a fellow in pediatric dermatology at the Children’s Memorial Hospital, Chicago with Amy Paller and Anthony Mancini and completed a master of science at the Northwestern University in the field of Clinical and Translational Research. Since 2007 she works at the CHUV were she established a reference center in pediatric dermatology. She received diverse awards and research grants leading to numerous publications. She is the secretary general of the European Society for Pediatric Dermatology, president of the pediatric dermatology training program committee, active member of the European task force on atopic dermatitis, honorary member of the French society for Dermatology and Venereology, expert for the phacomatosis network Romandie, as well as past president of the Swiss group for pediatric dermatology. Her translational research focus is on atopic dermatitis and on Line-field Confocal Optical Coherence Tomography
Prof Eli Sprecher (Tel Aviv, Israel)
Proteolytic and anti-proteolytic activity in skin diseases: gluing the pieces together
Eli Sprecher received an MD degree from the Hebrew University, a PhD degree in molecular virology from the Hebrew University and an MBA degree from Tel Aviv University. He specialized in dermatology at the Rambam Medical Center, Haifa, and spent a post-doctoral fellowship in human genetics at Thomas Jefferson University, Philadelphia. He was Deputy Director for Academic Affairs at the Rappaport Institute for Research at the Technion-Israel Institute of Technology, and founded as well as directed the Center for Translational Genetics at the same institution. He became Chair of the Department of Dermatology at the Tel Aviv Medical center in 2008, Professor of Dermatology at the Sackler Faculty of Medicine, Tel Aviv University in 2010 where he also received the Frederick Reiss chair of Dermatology in 2014. He also serves as Deputy Director General for Research and Development at the Tel Aviv medical center. He has co-authored over 300 scientific publications, has mentored over 50 students and has received numerous national and international honors. His research focuses on the genetic basis of skin diseases. His group aims at understanding the molecular genetics of both simple and complex traits, deciphering their pathogenesis and then attempting at translating this new knowledge into innovative therapeutic tools.
Dr Leong Kin Fon (Kuala Lumpur, Malaysia)
Education in AD
Dr Leong Kin Fon is a consultant paediatric dermatologist from General Hospital Kuala Lumpur. Dr Leong has been active in medical research, and has presented in numerous local and international conferences. Dr Leong has also authored and co-authored more than 50 scientific publications and books; among which include The Faces of Atopic Eczema among Malaysian Children and the Atlas of Paediatric Diseases series.
Dr Leong is the president of the Malaysia Eczema Society and Malaysian Dystrophic Epidermolysis Bullosa Research Association (DEBRA Malaysia) since 2020 and 2013 respectively
He actively volunteers with various national & international humanitarian organizations such as MERCY, TIMA and Medecen San Frontier.
He was given ILDS humanatarian award in 2017 .
Dr Leong has special interest in eczema, acne, psoriasis, birthmarks, portwine stain, nevus of Ota hemangioma, vascular lesions and common skin problems in children, adolescent and young adults
Prof Sandipan Dhar (West Bengal, India)
Atopic Dermatitis in Skin of Colour
Dr.Sandipan Dhar is a Pediatrc Dermatologist & an expert on Atopic Dermatitis. He has so far published 253 scientific papers in peer reviewed journals . He has authored six books on Dermatology includind the First book on ‘Pediatric Dermatology’ from India and subcontinent. He is the Editor Emeritus of Indian Journal Of Dermatology, Editor-in-chief, Indian Journal of Paediatric Dermatology( IJPD), and a member of the editorial board of several journals in Dermatology and Paediatric Dermatology .He has been the guide of thesis of many post graduate students ( MD Pediatrics) on Pediatric Dermatology at Institute of Child Health, Calcutta University, India.
His fields of interest are Pediatric Dermatology, Atopic Dermatitis , Urticaria and Adverse cutaneous drug eruptions.
He is one of the key persons for establishing the subspeciality ‘ Pediatric Dermatology’ in India. He is currently the President of Indian Society For Pediatric Dermatology(ISPD) .He has also been a pioneering researcher on ‘ Atopic Dermatitis’ in India and subcontinent and organised the first ever conference on Atopic Dermatitis along with Dr.Deepak Parikh, former National President of IADVL at Mumbai in 2104. Currently he is a councilor , International Eczema Council(IEC). He is a F 1000 prime expert on Atopic Dermatitis. He is a Scientific member of SPIN.
He has been selected for Dr. Surrinder Kaur award for outstanding contribution to Pediatric Dermatology in India & Southeast Asia by International Society of Pediatric Dermatology. He has also been elected as member, Board of Directors, International Society of Pediatric Dermatology.
He has Chaired sessions, delivered lectures on Pediatric Dermatology & Atopic Dermatitis in various important national and global conferences & various premier institutes across the world
Prof Sebastien Barbarot (Nantes, France)
Epidemiology of AD
Sébastien Barbarot, MD, PhD, is an assistant professor of dermatology in the University Hospital of Nantes, France. He is the head of the Pediatric Dermatology Clinical Trial Unit and the head of the Eczema School in Nantes University Hospital since 2009. Sebastien was a postdoctoral fellow in 2013-2014 in the Centre of Evidence Based Dermatology, University of Nottingham UK. His mentor, Pr Jean-Francois Stalder is one of the founding fathers of the SCORAD score. His research is focused on the causes, prevention and treatment of atopic dermatitis in children and adults. He has been funded for an academic randomised clinical trial on the role of education in the management of children with atopic dermatitis and a randomised clinical trial on the role of prebiotics in pregnant women on the prevention of atopic dermatitis. Sebastien is Vice-chair of the European task Force in Atopic Dermatitis, President of the French society of Pediatric dermatology and Co-Chair of the French Academic Group on Atopic Dermatitis (Groupe de Recherche sur l’Eczema Atopique – GREAT ). Sebastien published 230 peer-reviewed papers.
Looking Beyond Paediatric Dermatology
Session Chairs: Carsten Flohr (London, UK) and Tess McPherson (Oxford, UK)
Dr Pamela McHenry
In memory of Olivia Schofield
After graduation from Queens University Medical school, Belfast, Pamela undertook general medical training in the Royal Victoria Hospital Belfast and Aberdeen Royal Infirmary. Specialist Dermatology training was based in Glasgow, where she developed her passion for paediatric dermatology. She also undertook a secondment to Great Ormond Street. Pamela was appointed Consultant Dermatologist in Glasgow working at the Western Infirmary and the Royal Hospital for Sick Children.
She found a kindred spirit in her Edinburgh counterpart Dr Olivia Schofield. They became firm friends through their common passion for paediatric dermatology and interest in teaching and sharing knowledge.
Together they established the Scottish Paediatric Dermatology Specialist interest Group to provide a forum for all Scottish Dermatologists to address particular challenges related to diagnosis, management and delivery of services to children with skin problems in Scotland. Both were Presidents of the British Society of Paediatric Dermatology but worked together on the BSPD committee in a variety of roles for many years. Pamela’s talk will reflect on Olivia’s passion for sharing knowledge for the benefit of patients.
Prof Celia Moss
Human factors in paediatric dermatology
Celia Moss is a Consultant Dermatologist at Birmingham Children’s Hospital and Honorary Professor of Paediatric Dermatology at the University of Birmingham. She trained in Medicine at Oxford University and University College Hospital, London, and in Dermatology in Newcastle-upon-Tyne. Previous national appointments include Chair of the British Society for Paediatric Dermatology, Chair of the UK NHS Clinical Reference Group for Specialised Dermatology, Convenor for Dermatology at the Royal College of Paediatrics and Child Health and Council Member of the Royal Society of Medicine Dermatology Section. She is a member of the advisory boards of several dermatology journals and patient support groups. She lectures, advises and publishes widely on genetic and paediatric dermatology, and has contributed chapters to the major UK and US textbooks. She was awarded the Sir Archibald Gray Medal and an OBE in 2016. Now semi-retired, she and her husband travel whenever possible, supporting colleagues overseas, particularly in India.
Prof Hywel Williams
On the philosophy of disease diagnosis
After training in dermatology at St. Johns in London, Hywel joined the University of Nottingham in 1994 where he founded the Centre of Evidence-Based Dermatology. He also serves as a consultant paediatric dermatologist at Nottingham University Hospitals NHS Trust. In addition to promoting the general principles of integration of good external evidence to the care of individual patients, Hywel’s specific lifelong research interest is atopic eczema – developing diagnostic criteria, understanding causes and prognosis, along with evaluating treatments and prevention. His main research methods include independent randomised clinical trials and systematic reviews, and he is one of the most cited clinical dermatologists in the world. Hywel cares passionately about research that is directly relevant to everyday practice and is a champion of public and patient involvement in research. Outside of dermatology, Hywel directed the NIHR Health Technology Assessment Programme from 2015 to 2020 and he continues to act as a senior national advisor on COVID-19 research oversight. Hywel is a proud holder of the British Association of Dermatologists Sir Archibald Gray medal, is an NIHR senior investigator and fellow of the Academy of Medical Sciences. At home, he keeps chickens, cats, coral fish and a large walled garden, and is unable sit still for more than 10 minutes.
Prof Sara Brown
Why do research?
Sara Brown is Professor of Dermatology in NHS Lothian and a Wellcome Trust Senior Research Fellow at the University of Edinburgh. Sara trained in dermatology in Newcastle-upon-Tyne and fell in love with paediatric dermatology. Sara’s MD research (supervised by Nick Reynolds, Heather Cordell and Caroline Relton) was the first population-based study of filaggrin null mutations, showing a small but significant effect in the mild eczema that is prevalent in the paediatric population. Sara moved to Dublin for a post-CCT fellowship in paediatric dermatology, training with Alan Irvine and Rosemarie Watson, before relocating to Dundee, for further training in epithelial genetics, in Irwin McLean’s lab. Sara’s current work seeks to understand atopic eczema from different perspectives, with the ultimate aim of improving treatment for this very challenging disease. The Brown Lab combines molecular genetics with skin organoid modelling, genome-wide analyses and genetic epidemiology, public engagement and therapy development.
Dr Cristina Has (Freiburg im Breisgau, Germany)
Latest classification of EB
Prof. Dr. med. Cristina Has
Dept. of Dermatology University of Freiburg, Germany
My clinical activity is includes general and pediatric dermatology, with focus and genodermatoses. I am internationally recognized for my work on the genetic basis of genodermatoses, in particular of skin fragility disorders. With my group, I have identified new genes and characterized large cohorts of patients with genodermatoses, established genotype-phenotype correlations and explored the underlying disease mechanisms.
2012- | Dermatologist, Professor, University Freiburg |
2009 | Board Exam. Dermatology Germany |
2007 | Habilitation in Experimental Dermatology, University Freiburg |
2003- | Head of Laboratory Molecular Dermatology, Department of Dermatology, University Freiburg |
2001-2003 | Postdoc, Centre National de Genotypage Evry France |
2001 | M.D., Medical University Cluj |
1999-2001 | Postdoc, Department of Dermatology Münster |
1998-2001 | Assistant professor Dermatology, Medical University Cluj |
1995-1998 | Assistant professor Genetics, Medical University Cluj |
1995 | Board Exam. Dermatology Romania |
1991 | Diploma degree in Medicine, Medical University Cluj, Romania |
Selected appointments, scientific activities
2021
2020 |
Associate Editor Frontiers in Medicine
Section Editor JDDG |
2020 | Co-coordinator of the subthematic group Epidermolysis bullosa if the ERN-Skin |
2019 | Appointment as Professor for Precision medicine of inflammatory skin disorders, University Lübeck – denied |
2019 | Associate Editor OJRD |
2019 | Advisory Editorial Board CED |
2019 | Co-Chair – Epidermolysis bullosa consensus classification |
2018 | Member of Debra Scientific Advisory Board |
Peer reviewed publications: 222
https://pubmed.ncbi.nlm.nih.gov/?term=has+c&sort=date
Prof John McGrath (London, UK)
Research Update
John McGrath is the academic head of St John’s Institute of Dermatology in London where he also runs the Genetic Skin Disease Group. He holds the Mary Dunhill Chair in Cutaneous Medicine at King’s College London and is Honorary Consultant Dermatologist to the Guy’s and St Thomas’ NHS Foundation Trust. He has lead roles in developing and delivering experimental medicine and in running several national rare skin disease projects in the U.K. His clinical and research work focuses on the diagnosis of inherited skin diseases and the development of novel treatments for rare skin diseases.
Dr Anna Bruckner (Colorado, USA)
Severe forms of EB are systemic disorders: Anemia as a Paradigm
Dr. Bruckner is a Professor of Dermatology and Pediatrics at the University of Colorado School of Medicine and Director of Pediatric Dermatology at Children’s Hospital Colorado. She attended Northwestern University as part of the Honors Program in Medical Education, earning her MD in 1997. She completed residencies in pediatrics and dermatology at the University of Colorado followed by a fellowship in pediatric dermatology at the University of California San Francisco.
Dr. Bruckner is passionate about improving outcomes and quality of life for children with skin disorders through patient care, research, education and advocacy. Her academic interests include genetic skin disorders, particularly epidermolysis bullosa (EB), vascular anomalies, and complex patients. She is the dermatology director for the regional EB center at Children’s Hospital Colorado and a founding member of the Epidermolysis Bullosa Clinical Research Consortium, a network of North American EB care centers collaborating in clinic research aimed at improving care and outcomes for patients with EB.
Dr Anna Martinez (London, UK)
4 stages of EB and an update on MissionEB
Dr Anna Martinez is a senior Paediatric Dermatologist at Great Ormond Street Hospital and Honorary Senior Lecturer at The Institute of Child Health, University College London. Anna trained at St Bartholomew’s Hospital and was appointed as a Consultant in Paediatric Dermatology at Great Ormond Street Hospital in January 2003. Since her appointment Anna has led the Highly Specialised Nationally Commissioned Service for Paediatric Epidermolysis Bullosa. Anna is a major contributor to research in the field of paediatric dermatology, she is Chief Investigator and Principal Investigator on a rolling programme of clinical trials into novel therapies for rare diseases.
Dr Agnes Schwieger-Briel (Switzerland)
Renal disease in EB
Agnes Schwieger- Briel, MD
Board certified paediatrician and dermatologist
Position
Staff paediatric dermatologist at the University Children’s Hospital Zurich (Head: Lisa Weibel)
Medical Head of EB-KIDZ (Paediatric EB Center Zurich, Switzerland)
Special interest: Genodermatoses, Epidermolysis bullosa
Training in paediatrics in Freiburg Breisgau, Germany (Head: Matthias Brandis)
Training in dermatology in
-University of Toronto,
Hospital for Sick Children, Canada (Head: Elena Pope)
-University Hospital Freiburg, Germany
Department of Dermatology, EB-center Freiburg (Leena Bruckner-Tuderman)
-University Hospital Zürich, Dermatology (Head: Lars French)
University Children’s Hospital Zurich (Lisa Weibel)
Ichthyosis and Ectodermal Dysplasia
SESSION CHAIRS: DR ANGELA HERNANDEZ & PROF. DR. PETER STEIJLEN
SESSION SPEAKERS:
Prof Juliette Mazereeuw-Hautier (Toulouse, France)
Therapies for icthyosis – what works and what’s new
Pr J Mazereeuw-Hautier practices at Larrey University Hospital in Toulouse. Pr J Mazereeuw-Hautier’s practice encompasses all aspects of pediatric dermatology and rare genetic skin diseases. She is a widely recognized expert in these fields and has particular expertise in congenital ichthyosis. Pr J Mazereeuw-Hautier has authored over 190 publications, speaks at national and international conferences, and has served as an investigator on numerous clinical trials.
Prof. Dr. Peter Steijlen (Maastricht, The Neterlands)
20 year Ichthyosis Service
Since 2002 Peter Steijlen is the head of the department of dermatology at the Maastricht University Medical Centre+, the Netherlands. Genodermatology is one of the main interests of the department. The Maastricht University Medical Centre+ is recognized by the Dutch Ministry of Health as a Centre of Expertise for Genodermatoses.
Dr Angela Hernandez-Martin (Madrid, Spain)
Congenital ichthyosis: lessons learnt from a multidisciplinary clinic
Senior Consultant Pediatric Dermatologist at Hospital Infantil NIño Jesús, Madrid, Spain. Her main areas of interest are keratinization disorders and neurocutaneous diseases. She has co-authored numerous PubMed indexed publications in these and other fields of pediatric dermatology.
Prof Jemima Mellerio (London, UK)
Care of the neonate with ichthyosis
Prof Jemima Mellerio trained in dermatology in South London at St John’s Institute of Dermatology and King’s College Hospital. Undertaking her MD at St John’s Institute on Genotype-Phenotype Correlations in Epidermolysis Bullosa (EB) sparked an interest in genetic skin fragility disorders that has endured. She has been a consultant dermatologist since 2003 and is based at St John’s Institute of Dermatology, Guy’s and St Thomas’ Hospital, London where she is Chief of Dermatology and leads the Adult Epidermolysis Bullosa (EB) Service which provides clinical care for around 500 individuals with EB. She also worked as the dermatologist to the Paediatric EB Service at Great Ormond Street Hospital for almost 15 years until recently. Jemima’s clinical interests are EB, Mendelian genodermatoses, and general paediatric dermatology. She has established a large tertiary referral service at St John’s for both adults and children with genetic skin disease, overseeing the care of a large cohort of patients with ichthyosis, palmoplantar keratodermas, other disorders of keratinisation and ectodermal dysplasias. She has active clinical and laboratory research interests in many different aspects of genetic skin disease including gene discovery and phenotyping, a longitudinal prospective study in recessive dystrophic EB, and translational research of new therapies for genodermatoses including cell and gene therapy. She has published widely and lectured nationally and internationally on these areas.
Dr Vinzenz Oji (Muenster, Germany)
Title TBC
Dr Fanny Morice-Picard (Bordeaux, France)
Hereditary muco-epithelial dysplasia and IFAP syndrome – disorders of the SREBP pathway
Fanny Morice-Picard started her medical studies in Rouen (France). She moved to Bordeaux as a resident where she was trained in medical genetics and dermatology. She did a Master in Molecular Genetics in Paris (Hôpital Necker-INSERM U393) in 2003-2004. She graduated in Medical Genetics and obtained her PhD in Biological Sciences “Molecular Genetics” (University of Bordeaux, 2013). She spent 4 years as Senior Registrar in Medical genetics unit and shared her time between clinical activity, molecular diagnostic and research. FMP started working in Dermatology department as hospital practitioner and is involved in the activity of the Reference Centre for Rare Skin Disorders, CHU de Bordeaux founded by Pr Alain Taïeb in 2005.
FMPs main professional activities include management and care of patients with rare inherited skin disorders and research on physiopathology and genetics causes of skin diseases. She is involved in different projects on DNA repair disorders and pigmentary disorders. She collaborates with the moleculargenetic diagnostic laboratories and took part in the design and analysis of sequencing panels dedicated to genodermatoses including albinism, genetic disorders of pigmentation, hypotrichoses, DNA repairs disorders.
Dr Isabel Colmenero (Madrid, Spain)
Dermpath of Vascular Anomalies
Isabel Colmenero, MD, graduated from the Universidad Central de Venezuela in 1993 getting the First of the Class Special Award. She trained in pathology at Hospital Universitario San Carlos in Madrid where she first developed her interest for Pediatric Pathology and Dermatopathology.
As soon as she finished her training in pathology, she started a career in pediatric surgical pathology at Hospital Universitario Niño Jesús, the leading children´s hospital in Madrid, where she has been working since 1999. Since 2006 she took over the role of Clinical Lead for Dermatopathology, developing her academic and scientific interest in skin disorders of children, particularly vascular anomalies, autoinflammatory skin disorders, cutaneous mosaicisms, and mastocytosis. Together with the Pediatric Dermatology team at Hospital Niño Jesús, she has co-authored many scientific papers on pediatric skin disorders, including the description of new genetic mechanisms of disease and new clinicopathological entities.
Dr Colmenero is an author of 120 scientific peer-reviewed papers on topics in pediatric pathology and dermatopathology, including the seminal descriptions of entities such as CANDLE syndrome, PENS nevus, PENS syndrome, Skeletal Muscle Nevus and Perforating Neutrophilic and Granulomatous Dermatitis of the Newborn (APLAID syndrome). She is author of 5 book chapters, and she is editing the book Pediatric Dermatopathology for Cambridge University Press. She has been a long-serving member of the Pediatric and Developmental Pathology journal editorial board, has recently joined the editorial board of Pediatric Dermatology and is a regular referee for many international journals in dermatopathology. She is a frequent invited speaker to pediatric pathology and dermatopathology international meetings around the world, and has been the organizer of the 2012 International Paediatric Pathology Association (IPPA) Advanced Course of Paediatric Pathology in Segovia and the 58th Annual Meeting of the Paediatric Pathology Society in Madrid.
Dr Colmenero is a founder member of the Spanish Society of Vascular Anomalies, and she set up and is currently the Chair of the National Panel of Pathologists for Vascular Anomalies, delivering expert opinions for complex cases in Spain and other European Countries. She is an active member of many international scientific societies including Paediatric Pathology Society (PPS), Latin-American Society of Pediatric Pathology (SLAPE), British and Irish Paediatric Pathology Association (BRIPPA), European Society of Pathology (ESP), Working Group of Pediatric and Perinatal Pathology of the ESP, Spanish Society of Pathology (SEAP), Pediatric Pathology Group of the SEAP, International Society for the Study of Vascular Anomalies (ISSVA), Spanish Society of Vascular Anomalies (SEAV), Spanish Group for the Study of Cutaneous Mosaicisms and Spanish Group of Dermatopathology (GED). She is serving as a Council member of the IPPA, and also as a member of the PPS Committee. She is the Chair of the Working Group of Pediatric and Perinatal Pathology of the ESP since 2018.
She was Associate Professor of Pathology at Universidad Autónoma de Madrid School of Medicine, and is involved in teaching of pediatric pathology and dermatopathology to undergraduate and postgraduate students. She is a tutor in the International Master of Dermatopathology and Clinicopathological Correlation at the Alcalá de Henares University in Spain. She has been lecturer in the Master of Pediatric Oncology at the University of Birmingham.
Dr Colmenero has been involved as principal investigator or collaborator in many research projects related to pediatric tumors, transplant pathology, celiac disease, Hirschsprung disease, biobanking, vascular anomalies, cutaneous mastocytosis and Covid-19.
She moved to the UK in 2013 to undertake the role of Consultant Pediatric Histopathologist and then Head of the Histopathology Department at Birmingham Children´s Hospital (BCH), one of the largest pediatric hospitals in the UK. During her time in Birmingham she developed the clinical leadership in Dermatopathology and was also the clinical lead for pediatric oncology, neuro-oncology and retinoblastoma. She was named principal investigator of the Biobank at BCH. She was working close together with the Retinoblastoma team as histopathology research lead and as a result of this collaboration, in 2018, Dr Colmenero participated in the Retinoblastoma Network Workshop in Dar es Salaam, Tanzania, a project funded by the Queen Elizabeth Diamond Jubilee Trust and held by the London School of Hygiene & Tropical Medicine; designed to provide practical training in the management and planning for up scaling retinoblastoma services in Tanzania.
In 2016, Dr Colmenero moved back to Spain, where she continued with her work at Hospital Niño Jesús, keeping her liaison with BCH as an Honorary Consultant.
Dr Saleem Taibjee (Dorset, UK)
Useful (Histological) Clues in Assessing Blistering Disorders
I am a Consultant Dermatologist and Dermatopathologist at Dorset County Hospital, Dorchester, one of a select few UK Dermatologists seeing patients including paediatric dermatology, and also reporting skin histopathology, and providing second opinions.
I completed Specialist Training in Dermatology in the West Midlands in 2007, developing Dermatopathology as sub-specialist interest, passing Royal College of Pathologists Diploma in Dermatopathology. Previous posts include Consultant Paediatric Dermatologist at Birmingham Children’s Hospital 2007-13, Consultant Dermatologist at University Hospital Birmingham 2007-9 and Consultant Dermatopathologist at University Hospital Coventry & Warwickshire 2009-13.
I am a member of Royal College of Pathologists Specialist Advisory Committee on Dermatopathology, Steering Group for National Specialist Dermatopathology EQA Scheme, past-member of Steering Group for UK Dermatology Clinical Trials network and past-Secretary of British Society for Dermatopathology.
Dr Sylvie Fraitag (Paris, France)
Neonatal life-threatening diseases : usefulness of cutaneous biopsy
Senior consultant dermatopathology
Head Dermatopathology division
Hôpital Necker-Enfants Malades – Paris, France
Pathologist and Dermatologist
University Lecturership:
Board Certification of Pathology
Board Certification of Dermatology
University Certification of Dermatopathology.
Inter-university Certification in Paediatric Dermatology
European School of Pathology
EADV Winter School “Basics of Dermatopathology”
EADV Summer School ”Advanced Dermatopathology”
Member of the Examination Committee of the European Dermatopathology Examination (ICDP, UEMS)
Affiliation
French Society of Dermatology
French Society of Pathology
French Society of Pediatric Dermatology
French Society of Pediatric Oncology
International Society of Dermatopathology
French Group for Study and Research of Cutaneous Lymphomas Member of MAGEC (National Reference Centre for Genodermatoses)
National Reference Centre for Mastocytoses
National Reference Centre for Histiocytoses
European Academy of Dermatology and Venereology
International Society for the Study of Vascular Anomalies
Past-Member of the Executive Committee of the International Society of Dermatopathology
Original articles, article reviews, case reports:
325, most of them in Pediatric dermatology/dermatopathology in International Journals indexed in Pubmed
95 not indexed in Pubmed
Book chapters: 23
Books (as co-editor): 4 (Elsevier and Sauramps publishers)
Dr Ashfaq Marghoob (New York, USA)
Leveraging imaging technologies for melanoma detection
Dr. Ashfaq A. Marghoob is a dermatologist specializing in the diagnosis and treatment of cancers of the skin. He is the director of the Memorial Sloan-Kettering regional skin cancer clinic located in Hauppauge, Long Island. In addition to consulting and treating patients on Long Island, he also sees patients at the Memorial Sloan-Kettering outpatient facility in Manhattan. Although, providing the best care possible for patients is his primary objective, he remains committed to education and research. Dr. Marghoob’s belief is that improved efforts in educating physicians and the public regarding the importance of early skin cancer detection will translate into lives saved. His clinical research has led to the publication of numerous peer reviewed manuscripts and book chapters on topics related to skin cancer with an emphasis on melanoma, acquired melanocytic nevi, congenital melanocytic nevi and basal cell carcinoma. The focus of much of his research is on early recognition of skin cancer by utilizing imaging instruments such as photography, dermoscopy and reflectance confocal microscopy. He continuously explores the importance and significance of the clinical and dermoscopic morphology of cutaneous lesions. Although his research efforts are primarily focused on discovering ways to improve clinician diagnostic accuracy, he remains engaged in research aimed at deciphering the natural biology of nevi and melanoma with a particular interest in nevogenesis and melanomagenesis. Dr. Marghoob frequently lectures on all of the aforementioned topics both nationally and internationally.
Prof Alberto Pappo (Memphis, USA)
Surveillance imaging in paediatric melanoma
Alberto S. Pappo, M.D. is a Member; Director, Solid Tumor Division; Co-Leader, Developmental Biology and Solid Tumor Program in the Department of Oncology at St. Jude Children’s Research Hospital. Dr. Pappo rejoined the faculty in 2010 and is a pediatric oncologist who has been interested in the study of sarcomas and rare cancers for 20 years.
Dr. Pappo received his medical degree from Universidad Anahuac School of Medicine, Mexico City in 1984. Following medical school, he completed his pediatric residency at the University of Texas Health Science Center in San Antonio, TX and his fellowship in Pediatric Hematology Oncology at Children’s Medical Center of Dallas and the University of Texas Southwestern Medical Center in Dallas TX. Dr. Pappo was an Associate Member in the Department of Hematology-Oncology, at St. Jude Children’s Research Hospital from 1997-2001 and later rejoined the faculty staff in 2010 at St. Jude.
Dr. Pappo has been the principal investigator of three prospective national clinical trials for the treatment of childhood rhabdomyosarcoma. In addition, he was the chair of the rare tumor committee of the Children’s Oncology Group from 2001-2008. During this time he developed the clinical infrastructure needed to conduct trials in pediatric rare tumors and facilitated the development of a trial to enhance the ability to collect tumor samples from these patients. More recently he was the US PI for the IGF1-R monoclonal antibody R1507. Dr. Pappo’s current interests are to develop rational clinical studies for pediatric sarcomas based on robust animal models that are being developed by Dr. Michael Dyer. His research interest is in developing novel therapies for pediatric solid tumors with special interest in: pediatric melanoma, soft tissue sarcomas and pediatric gastrointestinal stromal tumors.
Immune & Connective Tissue Diseases
SESSION CHAIRS: PROF BERT CALLEWAERT & LISA WEIBEL
SESSION SPEAKERS:
Dr Arti Nanda (Kuwait)
Autoimmune Skin Manifestations and Immunodeficiency
Consultant Dermatologist, Head of Unit Pediatric Dermatology As’ad Al-Hamad Dermatology Center, Kuwait
Executive Board Director, International Society of Pediatric Dermatology (ISPD) (Since July, 2017)
- Member, Editorial Advisory Board, International Society of Pediatric Dermatology (July 2014-June 2017)
- Editorial Member, Pediatric Dermatology Journal (USA)
- Member, Editorial Advisory Board, Pediatric Dermatology Journal (USA), (1994-1998)
- Fellow Royal College of Physicians (FRCP), Edinburgh, UK (Since January 2014)
- Published more than 140 papers in International Peer Reviewed Journals
- Invited Speaker & Chair/Co-chair in International/National Conferences, Dermatology/Pediatric Dermatology since 2003
Dr Lisa Weibel (Zürich, Switzerland)
Localised Scleroderma
Lisa Weibel is a board certified Pediatrician and Dermatologist. Following her 2-year specialist training in Pediatric Dermatology at Great Ormond Street Hospital for Children in London, she started in 2009 to establish the Pediatric Skin Center in Zurich at the University Children’s Hospital, which today sees 8000 out-patients per year under her lead and 3 more full-time Pediatric Dermatology Consultants.
Lisa Weibel achieved her MD-Thesis in 2001 and her associate professorship in 2016 from the University of Zurich. Her areas of interest are vascular anomalies, neonatal dermatology, morphea and rare skin diseases. She has published >95 peer-reviewed articles (incl. 47 original articles) and is the author of several book chapters in international textbooks. Her academic mentoring activities have supported 8 physicians to become full-time Pediatric Dermatologists. She is a Board Member of the ESPD, the European Hemangioma Task Force, the Swiss Group for Pediatric Dermatology (SGPD), President of the Swiss Group for Vascular Anomalies and Member of the International Society for the Study of Vascular Anomalies (ISSVA).
Dr Jennifer Huang (New York, USA)
Graft versus host disease: Top 10 things a pediatric dermatologist should know
Jennifer T. Huang, MD is a board certified pediatric dermatologist at Boston Children’s Hospital, Boston, MA and Associate Professor of Dermatology at Harvard Medical School. She received her BA in Medical Anthropology at Brown University and obtained her medical degree at Washington University School of Medicine. She completed pediatrics residency at Morgan Stanley Children’s Hospital in New York City, dermatology residency at University of Colorado-Denver, and pediatric dermatology fellowship at Boston Children’s Hospital.
She holds a clinical appointment at Dana-Farber Cancer Institute, and specializes in pediatric oncodermatology, with clinical and research interests in graft-versus-host disease, skin cancer in childhood cancer survivors, and cutaneous reactions to targeted anticancer therapies. She also currently serves as the Program Director for the Harvard Combined Dermatology Residency Training Program, and has engaged in various aspects of medical education and innovation.
She is a member of the American Academy of Dermatology, Society for Pediatric Dermatology, and Pediatric Dermatology Research Alliance.
Dr Antonio Torrelo (Madrid, Spain)
Update on Autoinflammatory Disorders
Prof Bert Callewaert (Ghent, Belgium)
A Clinically Oriented Classification of Cutis Laxa Syndromes
Bert Callewaert is a pediatrician and clinical geneticist. He graduated from Ghent University in 2004, and received his scientific and clinical training (2004-2011) at Ghent University and Ghent University Hospital. In 2008, he was a research fellow at Washington University School of Medicine in St-Louis, MO under supervision of Dr. Zsolt Urban. He obtained his PhD degree in Medical Sciences from Ghent University in 2010. In 2014, he was appointed Associate Professor at Ghent University and has teaching assignments in molecular biology, clinical genetics, and pediatrics. Since 2014, he is head of Clinic at the Center for Medical Genetics of Ghent University Hospital. As a Senior Clinical Investigator of the Research Foundation – Flanders, he leads a team that investigates the pathophysiology of diverse Mendelian connective tissue disorders and intellectual disability syndromes using cellular systems and animal modeling in zebrafish and mice. He contributed to over 130 research papers and book chapters. He obtained international recognition for his work on arterial tortuosity syndrome and cutis laxa syndromes. He is active in several national (Belgian Society for Human Genetics) and international organizations for (clinical) research and patient care (European reference networks for skin disorders (ERN-skin), vascular disorders (VascERN) and for congenital malformations and intellectual disability (ITHACA), Cutis laxa internationale, A Twist of Fate-ATS, Myhre syndrome Foundation) and participates actively in the organization of heath care for rare disorders (Flemish network for rare disorders).
Prof. Dr. Beatrix Volk-Platzer (Vienna, Austria)
Use of IVIG in Children
Professor Beatrix Volc-Platzer, MD, is a board-certified dermatologist and venerologist, and associate professor of Dermatology and Venerology with main topics immunodermatology, dermatohistopathology and pediatric dermatology. Beatrix Volc-Platzer graduated in 1978, at the University of Innsbruck, Austria. From 1979 to 1980 she was a resident at the Institute of Pathology, University of Vienna. From 1980 to 1987 Training in Dermatology and Venerology at the Departments of Dermatology at the Universities of Innsbruck and Vienna, Austria (Head: Professor Klaus Wolff, MD) and member of the immunodermatology team of Professor Georg Stingl, MD. “Habilitation“ 1989, Associate Professor 1995. 1992 – 1994 Researcher at the former Sandoz Reseach Institute in Vienna for the project „Gene therapy for AIDS“. 2001 appointed Head of the Department of Dermatology at the Donauspital SMZ Ost, Vienna, Austria. Retired in 2019.
1994 to 1999 Board Member of the European Society of Dermatological Reseach (ESDR), 2008 to 2010 President of the Austrian Society of Dermatology and Venerology (ÖGDV). Head of the Working Party for Paediatric Dermatology of the ÖGDV and founder of the Karl Landsteiner Institute for Paediatric Dermatology in 2012. Beatrix Volc-Platzer is Vice-President of the Karl Landsteiner Society and has been appointed as first woman president of the “College of Physicians in Vienna” (Gesellschaft der Ärzte in Wien), on October 28th, 2020.
The research and clinical topics include immunopathology of Graft-versus-host Disease, diagnostic parameters and treatments of autoimmune diseases, i.e. connective tissue diseases and autoimmune bullous diseases, and paediatric dermatology. Publications include „Expression of class II alloantigens by keratinocytes” (J Exp Med 1984) and „On the bone marrow origin of human Langerhans cells“ (N Engl J Med 1984). Recent publications include “European Guidelines of IVIG” (J Eur Acad Dermatol Venereol and J Dtsch Dermatol Ges 2017), “EDF/EADV Guidelines on the treatment of cutaneous lupus/CLE (J Eur Acad Dermatol Venereol 2017), “Dermatomyositis” (Hautarzt 2015) and on rare diseases in children, e.g. (Br J Dermatol 2017, 2019, 2020). Contribution to Harper’s Paediatric Dermatology, 4th Ed., with the chapter on “Skin manifestations of Metabolic Syndrome”. Beatrix Volc-Platzer is “peer reviewer” for several journals, e.g. J Invest Dermatol, Br J Dermatol, Clin Exp Dermatol, Acta Dermatovenereol, J Dtsch Dermatol Ges, and was appointed “associate editor” for the Br J Dermatol in 2016.
1984 Hebra Award of the Austrian Society of Dermatology and Venerology (ÖGDV) for research on “Class II alloantigen expression on keratinocytes” and 1989 AESCA Award of the ÖGDV for “Sequential immunohistological analysis of the skin after allogeneic bone marrow transplantation”.
Founder of the annual interdisciplinary symposium of paediatric dermatology („Kinder-Haut-Tag“) in 2010, under the auspices of the ÖGDV, the Karl Landsteiner Society and the Austrian Society for Pediatrics.
Lecturer for the Medical University of Vienna on “Autoimmune Diseases of the Skin” and “Paediatric Dermatology”.
Beatrix Volc-Platzer and her husband live in Vienna. She has two children and two grand-children.
Prof Kieron Leslie (San Francisco, USA)
Cryopyrin – Associated Diseases
Infections & Infestations
SESSION CHAIRS: ASSOC PROF MARIE VICTORIA DIZON & DR ANTHONY MANCINI
SESSION SPEAKERS:
Dr Maria Trinidad Hasbun (Santiago, Chile)
Interesting Cases in Cutaneous Infections
Dr Trinidad Hasbun, Pediatric Dermatologist. Faculty of Medicine Universidad del Desarrollo y Clinica Alemana de Santiago. Hospital de Niños Exequiel González Cortés, Santiago, Chile.
Dr Jon Dyer (Missouri, USA)
Paediatric syphilis
Jonathan A Dyer, MD, is the Philip C. Anderson Chair of Dermatology at the University of Missouri. He is also Professor of Clinical Dermatology and Director of Pediatric Dermatology. He completed dermatology residency in 2002 and a fellowship in Pediatric Dermatology at Northwestern University in 2004. His primary clinical and research interests are Genetic skin diseases, cutaneous mosaicism, epigenetics, pediatric teledermatology and loxoscelism. He has publications and textbook chapters on a variety of Dermatology topics and is the author of the Inherited disorders of connective tissue chapter in Fitzpatrick’s Dermatology in General Medicine.
Associate Professor Maria Victoria C. Dizon (Manila, Philippines)
Bugs and infestation issues in Asia
Dr Arun Inamadar (Vijayapura, India)
Chikungunya: Profile of skin lesions in Pediatric age group
Dr. Arun C Inamadar MD, FRCP (Edinburgh) is in the forefront of developing ‘Pediatric Dermatology’ as a subspecialty in India.
He is presently Professor and Head, Dept. of Dermatology, Venereology & Leprosy, Sri B. M. Patil Medical College, Hospital & Research Center, BLDE Deemed University, Vijaypur -586103, Karnataka, India
He has teaching experience of almost 30 years with more than 200 publications. He has edited 10 books and contributed 60 chapters.
The ‘Text book of pediatric dermatology’ (two editions, Mc Graw Hill)/ Jaypee Publishers), is a first of its kind in Indian Pediatric dermatology literature. He has contributed a chapter in Harper’s Textbook of Pediatric Dermatology’ 4th edition.
He is Executive editor, Indian Journal of Pediatric Dermatology (IJPD). He is chief editor of ‘Clinical Dermatology Review’. He is member of Indian Society of Pediatric dermatology (ISPD) and Society for Pediatric Dermatology (SPD)
He is a regular resource for Pediatric Dermatology across India in various sate. Regional and national meets of the speciality. His areas of interest and research are emerging and re-emerging infections, clinical / medical dermatology, genodermatosis and critical care in dermatology.
Dr Messay Tesfayen (Addis Ababa, Enthiopia)
Infections and infestations in Ethiopia at a glance
Dr. Messay Tesfaye Demissie is a dermatovenereologist and an assistant professor of Dermatovenereology in Addis Ababa University college of health sciences which is a is a large, highly residential national university in Addis Ababa, Ethiopia. She is actively engaged in teaching Dermatovenereology for undergraduate medical students and post graduate doctors. She is particularly interested in peadiatric dermatology and she is the case team leader of peadiatric dermatology clinic in ALERT. She also works as a medical expert volunteer in the newly established artificial intelligence center.
Joint International Eczema Council – ISPD Symposium
Management of Pediatric Atopic Dermatitis : A Global Perspective
Session Coordinators:
Prof Carsten Flohr (London, UK)
Prof Amy Paller (Illinois, USA)
Please CLICK HERE to see the IEC Symposium programme in detail
Dr Graham Bisset (Sutton, UK)
Dermatology Lasers – Basic Science & Training Requirements
Dr Bisset is an independent and well-respected laser training consultant, with over 25 years experience in medical / aesthetic lasers and their clinical applications. He has attended over 370 national and international conferences and has lectured at the BMLA and on several UK NVQ and VTCT Level 4 Courses in Lasers & Light.
Dr Samira Batul Syed
Laser treatments for Birthmarks In Children including side effects of laser therapy
Dr Samira Batul Syed is an Associate Specialist in Paediatric Dermatology at Great Ormond Street Hospital for Children for the last 26 years and a Locum Consultant Paediatric Dermatologist at the Royal Free Hospital in London for the last 6 years.
Her special interest is in the field of Vascular Anomalies. She trained at University College Hospital Medical School in London and has gained 10 years of experience in paediatrics, neonatal medicine and community child health within the UK and abroad prior to joining GOSH. She was the pioneer with the Late Professor John Harper in starting the Laser Service for children at GOSH. She is an experienced laser specialist using lasers for the treatment of Birthmarks and Vascular Anomalies. She has trained many doctors in the applications of laser therapy. She is an executive member of various Associations including the British Medical Laser Association.
She is part of the Multi-Disciplinary Team caring for difficult and challenging patients with rare and complex vascular anomalies at GOSH.
Her research interest is in the development of new therapies for vascular anomalies, including novel drugs and implementing new concepts in laser therapies.
Dr Bisola Laguda
Setting up a laser unit (NHS/Private)
I have been a consultant in Paediatric Dermatology at the Chelsea and Westminster Hospital for the last 10 years.
I am currently the lead for Paediatric laser and vascular anomalies as well as the service director for Paediatric Medical specialities.
Dr Giulia Rinaldi
Free paper
Dr Declan Collins
Management of scars with lasers
Mr. Declan Collins is a Consultant in Plastic and Reconstructive Surgery, with specialist interests in Burns, Laser and Scar management.
He started the Laser Unit at Chelsea and Westminster Hospital for scar management as well as the laser hair removal service for the Gender Dysphoria Service.
He is Fellow of the Royal College of Surgeons of Edinburgh, a member of the British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS) and British Burn Association (BBA).
As well as working at Chelsea and Westminster Hospital he works at The London Scar Clinic.
Dr Zambia Kader (London, UK)
Laser applications for skin of colour
Dr Kader is Nuclear Medicine trained Consultant with a special interest in Nuclear Cardiology. She also holds a fellowship in Paediatric Nuclear Medicine from Great Ormond Street Hospital. Her passion for laser technology encouraged her to pursue and introduce lasers for cosmetic purposes in the UK. She was involved in introducing the Laser Hair removal in Britain and specialised in treating Asian and Afro-Caribbean skin types. She was trained by the Mayo Clinic Group in New York in advanced Laser technologies. Dr Kader has performed more than 200,000 treatments in the UK and internationally. She has presented in leading World Laser Congress Meetings. She is among the first group of doctors to be trained in Botox and fillers in the UK. She has a Fellowship in aesthetic medicine and is also a certified laser protection advisor (ALSP). Dr Kader is the chair person for the UK Council on Surgical Plumes (UKCSP). She has over 25 years’ experience in appetite suppressant related weight loss management and has a passion for Functional medicine and Nutrigenomics’
Faisal Ali (London, UK)
Laser applications for vitiligo and acne
Dr Alice Childs (London, UK)
Psychology support for children undergoing laser therapy
Alice is an Assistant Psychologist in the Dermatology department at Great Ormond Street Children’s Hospital (GOSH). Within this role she supports parents, young people and families with managing the challenges associated with having a dermatological condition including considering strategies for coping with visible difference, managing difficult social situations and anxiety management. Prior to this role Alice worked with children and young people for 10 years in various roles, amongst which she spent two years as an Assistant Psychologist in a Child & Adolescent Mental Health Service (CAMHS) where she supported young people and their families with moderate to severe mental health problems. Alice has a 1st Class BSc Psychology degree from the University of Surrey and a PGCert in Children and Young People’s IAPT- Enhanced Evidence Based Practice. She has also undergone several trainings in Cognitive Behavioural Therapy and she has recently been accepted onto the highly competitive Doctorate in Clinical Psychology at Salomons, the South Thames Clinical Psychology doctoral programme.
Mixed Session
SESSION CHAIRS: DR RASHMI SARKAR
SESSION SPEAKERS:
Prof. Dr. Peter Höger (Hamburg, Germany)
Neonatal Skin
Peter H. Hoeger MD Cath. Children´s Hospital Wilhelmstift Hamburg
Depts. of Paediatrics and Paediatric Dermatology
D-22149 Hamburg, Liliencronstr. 130 (Germany)
Current Position
Head, Depts. of Paediatrics and Paediatric Dermatology and Medical Director, Cath. Children´s Hospital Wilhelmstift (Academic Teaching Hospital, Universities of Hamburg and Schleswig-Holstein)
Academic affiliation
Professor of Paediatrics and Dermatology, University of Hamburg
Residency Training
Paediatrics: Depts. of Paediatrics, Universities of Würzburg and Hamburg
Dermatology: Depts. of Dermatology, U Hamburg, and Great Ormond Street Hospital (GOSH), London (UK)
Research Fellowships Paediatric Dermatology: GOSH |
Paediatric Immunology: Harvard Medical School, Children´s Hospital, Boston (US) |
Paediatric Immunology: University of Zurich, Children´s Hospital, Zurich (Switzerland) |
Dr Beth Drolet (Milwaukee, USA)
Viruses, vaccines, and vulnerabilities; Three pandemic-related discoveries that will change pediatric dermatology
Dr. Drolet has over 20 years of leadership in academic medicine and currently serves as the Geneva F. and Sture Johnson Distinguished Chair of Dermatology at the UW-Madison. She has published over 160 manuscripts, and her research focuses on infantile hemangioma and rare vascular anomalies. Her lab uses next-generation sequencing (NGS) to identify genetic causes of vascular anomalies and is leveraging these discoveries to develop breakthrough medications that target the disease at its source. Her team is also leveraging NGS to explore complex pediatric disorders and employing artificial intelligence to build algorithms for the diagnosis of birthmarks. Her research is by the National Institute of Health, Society for Pediatric Dermatology, PeDRA, Sturge-Weber Foundation, Dermatology Foundation, and philanthropy.
Prof Albert Yan (Philadelphia, USA)
Reactive Infectious Mucocutaneous Eruptions
Dr. Yan is Professor of Pediatrics and Dermatology at the Perelman School of Medicine at the University of Pennsylvania. He previously served as Chief of the Section of Dermatology at the Children’s Hospital of Philadelphia from 2004-2020. Dr. Yan has been a past President of the Society for Pediatric Dermatology, is the immediate past Chair of the AAP Section on Dermatology Executive Committee, and was past Treasurer of PeDRA (Pediatric Dermatology Research Alliance). Dr. Yan is one of the editors-in-chief of the 3rd and 4th editions of Harper’s Textbook of Pediatric Dermatology. He has received teaching awards from the medical school and residency programs in pediatrics and dermatology, as well as the Master Clinician Award from the Children’s Hospital of Philadelphia. His areas of interest include acne, atopic dermatitis, hemangiomas and vascular anomalies and genetic skin diseases. Dr. Yan is also co-founder of Inner Archways LLC, a software startup company developing apps that facilitate communication among physicians.
Prof Sherief Janmohamed (Brussels, Belgium)
Risk factors for eczema herpeticum
Professor Sherief Janmohamed (1981, the Netherlands) obtained his MD degree (2006) and PhD degree (2014) at the Erasmus University Medical Center in Rotterdam, the Netherlands. His thesis entitled: ‘Infantile Hemangioma: Pathogenesis, Evaluation, and Therapy’, was supervised by Prof. Dr. Arnold Oranje and Prof. Dr. Maurice van Steensel. For his work, he has been awarded the ‘Ruggero Caputto’s Young Pediatric Dermatologist award’ (2015). From 2014-2018 he was a Resident in Dermatology, Venereology, and Allergy under the supervision of Prof. Dr. Jan Gutermuth at the University Hospital Brussels (UZ Brussel), Belgium; and from 2018-2020 he was a post-doctoral fellow at Northwestern University, Feinberg School of Medicine, Chicago IL, USA (Prof. Dr. Jonathan Silverberg).
Currently, Sherief Janmohamed is leading the Multidisciplinary Unit Pediatric Dermatology at the University Hospital Brussels and is appointed as professor at the ‘Vrije Universiteit Brussel’. As an Epidemiologist, he heads the Epi-Derm Research group – his research interests include atopic dermatitis and infantile hemangioma. Prof. Dr. Sherief Janmohamed is board-member of the ESPD and associate editor of ‘Pediatric Dermatology’.
Dr Branka Marinovic (Zagreb, Croatia)
Autoimmune blistering diseases in pregnancy – is there a risk for a baby?
Branka Marinović M.D., Ph.D. Croatia Professor and Chair, Department of Dermatology and Venereology, University Hospital Center Zagreb, University of Zagreb School of Medicine. Field of interest in dermatovenerology are autoimmune diseases of the skin, specially autoimmune blistering diseases. – Current president of Croatian Dermatovenereological Society of the Croatian Medical Association and Editor-in-Chief of the journal Acta Dermatovenerologica Croatica – Secretary General of European Academy of Dermatology and Venereology Chair of Strauss and Katz World Congress Fund Review Task Force of AAD and member of International Affairs Committee of AAD, member of ESDR, ESPD, WDS, European Dermatology Forum, honorary member of American Dermatology Association, German Dermatological Society, as well as Serbian, Macedonian and Montenegrinian Derm Societies – Invited speaker and chair at national as well as international congresses including EADV and AAD – Author of more than 100 articles in indexed journals and 60 chapters in books
Dr Carol Hlela (Cape Town, South Africa)
The face of atopic dermatitis in South Africa
Carol Hlela is an Associate Professor at the University of Cape Town (UCT) in South Africa. She heads the Paediatric Dermatology Unit, at the Red Cross Children’s Hospital, Cape Town, South Africa. Carol Hlela is an NRF rated and an African Academy of Science (AAS) (a subsidiary of the Bill amd Melinda Gate’s Foundation) funded investigator in both her laboratory- based and clinical research. She is widely published and sits in various national and international advisory boards within her field of research. She holds a DPhil in Clinical Medicine from Oxford University, England, UK as well as a Masters in Global Health Science, also from the same university, and a Paediatric Dermatology Fellowship, from Robert and Ann Lurie Children’s Hospital, Northwestern University, Chicago, Illinois, US. Carol Hlela is one of only two paediatric dermatologists in the South Africa, championing as a leading specialist in baby and child skincare. Her mission is to reduce skin conditions in babies and children, and become the voice in paediatric dermatology in Africa.
Mosaic Disorders
SESSION CHAIRS: DR HARPER PRICE & PROF PIERRE VABRES
SESSION SPEAKERS:
Dr Andrea Diociaiuti (Rome, Italy)
Patient pathway in mosaic disorders: the ERN-Skin mosaic group proposal
Andrea Diociaiuti is currently responsible for the Center of Chronic and Complex Disease and Genodermatoses of Bambino Gesù Children’s Hospital in Rome.
Graduated in Medicine in 1995 and specialized in Dermatology and Venereology in 1998 in the University of Sacred Hearth in Rome. He achieved the PhD in Oncological Dermatology and then a II level Master in Dermatological Surgery.
He is adjunct professor in Pediatric Dermatology at the Postgraduate School of the Catholic University of the Sacred Heart in Rome.
He is Coordinator and lecturer for the University of Tor Vergata in the II level Master on in Pediatric Dermatology.
Member of the scientific committee of the Italian Society for the Study of Vascular Anomalies and of the Italian Society of Pediatric Dermatology.
Representative for Bambino Gesù Childrens’ Hospital since 2016 in the European Reference Network for Vascular Anomalies (VASCERN), he is Co-leader of the subgroup of Nevi and Nevoid overgrowth for the European Reference Network on Rare and Undiagnosed Skin Disorders (ERN-Skin) since June 2015.
Prof Veronica Kinsler (London, UK)
The clinical relevance of a genetic diagnosis
Prof Keith Choate
Congenital Haemangiomas
Dr Les Biesecker (USA)
Proteus Syndrome
Prof Rudolph Happle (Freiburg, Germany)
Unsolved Mosaic Phenotypes
Rudolf Happle was born in 1938 in Freiburg, Germany. In 1986 he was appointed as Chairman, Department of Dermatology, University of Nijmegen, The Netherlands. In 1991 he was appointed as Chairman, Department of Dermatology, University of Marburg, Germany. During his professional career he has functioned as Founding President of the European Society for Pediatric Dermatology, and as President of the European Hair Research Society. Presently he works as a guest professor at the University Department of Dermatology in Freiburg (Germany).
His main fields of research are genodermatology, especially cutaneous mosaicism, and hair diseases, especially alopecia areata. In 2014, his book “Mosaicism in Human Skin” was published by Springer (Berlin).
He is an honorary member of the national Dermatological Societies of 15 countries as well as of the European Society for Pediatric Dermatology, the Dutch Society for Pediatric Dermatolotgy, and the Sociedad Latinoamericana de Dermatología Pediátrica. He is an elected member of the American Dermatological Association and of the German National Academy of Sciences Leopoldina. In 2008 he received an Award of Appreciation from the International League of Dermatological Societies. In 2016 he became Dr. honoris causa of the Universidad de Buenos Aires, Argentina.
Rudolf Happle is on the boards of Actas Dermo-Sifiliográficas (Madrid); American Journal of Medical Genetics; Annales de Dermatologie et de Vénéréologie; Archivos Argentinos de Dermatología; Dermatologica Sinica (Taipei); European Journal of Dermatology; Journal of the American Academy of Dermatology (1994-2008); Journal of the European Academy of Dermatology and Venereology; and Revista Argentina de Dermatología.
Prof Lionel Larue (Paris, France)
Mouse models for mosaic skin conditions
Lionel Larue is an INSERM research director of exceptional rank at the Institut Curie, France, in an INSERM-CNRS department acting as deputy director. For the past 30 years, his laboratory has been interested in molecular genetics involving the melanocyte lineage. In order to better understand the normal and pathological development of melanocytes the laboratory studies, in an integrative manner, the molecular and cellular mechanisms involved in melanocyte lineage establishment, homeostasis and transformation.
Mucosal, Hair & Nail Disorders
SESSION CHAIRS: PROF SANDIPAN DHAR & DR DEEDEE MURRELL
SESSION SPEAKERS:
Dr Paul Farrant (Brighton, UK)
How to make an accurate diagnosis in paediatric hair disorders
Dr Farrant is a consultant dermatologist and clinical lead of the dermatology department at Brighton and Sussex University Hospitals trust, England. His main subspeciality interest is hair and scalp disorders and he runs the regional hair disorders clinic. Dr Farrant was the founder of the British Hair and Nail Society and is a member of the European Hair Research Society.
Dr Farrant is a chapter author on disorders of hair and dermatoses of the scalp in the 2016 version of the Rook Textbook of Dermatology. He also wrote the chapter on psychological aspects of hair disorders in Practical Psychodermatology. Other recent publications in peer reviewed journals and invited submissions include reviews on hair loss in infancy and childhood, psoriasis and hair loss, hair loss in patients with inflammatory bowel disease and the British Association of Dermatologists’ guidelines for the management of alopecia areata.
Prof. Dr. Regina Betz (Bonn, Germany)
Novel genes for hypotrichosis simplex – what do they implicate?
Regina Betz is Professor of Dermatogenetics at the Institute of Human Genetics at the University of Bonn in Germany. After studying medicine at the University of Saarland and the Karolinska Institute Stockholm, she worked as postdoctoral fellow at the Karolinska Institute Stockholm, and the Universities of Freiburg, Bonn and Antwerp before she started her Emmy Noether young investigator research group in Bonn in 2004. In 2010, she was appointed as Heisenberg Professor for Dermatogenetics in Bonn which became tenure in 2015. The particular research focus of her working group is dermatogenetics, with a main interest in diverse forms of monogenic and genetically complex alopecias and hyperpigmentation disorders. The work, and primarily the elucidation of several disease genes, was rewarded by a number of prizes and awards and is documented in more than 140 publications, among them several publications in high ranking international journals (e.g. Nature Genet., Am J Hum Genet, J Invest Dermatol). Dr. Betz has a board qualification in Human Genetics.
Prof. Dr. Miloš Nikolić (Belgrade, Serbia)
Treatment of Alopecia Areata
Prof Dedee Murrell (Sydney, Australia)
Paediatric autoimmune blistering diseases
Professor Dedee Murrell is Chair of the Department of Dermatology at St George Hospital, University of NSW, in Sydney, Australia. She completed medical training at Cambridge and Oxford Universities, 3 years of internal medicine in the UK and USA, dermatology training at UNC-Chapel Hill, a fellowship in dermatopharmacology at Duke, blistering diseases and cell biology at New York University, and then became a clinical scholar at Rockefeller University, focussing on epidermolysis bullosa. She holds a doctorate on the pathogenesis of blistering disorders, her main subspecialty interest, and her current research focusses on the development and validation of clinical outcome measures for EB and the Autoimmune blistering diseases which have enabled clinical trials to proceed in these orphan diseases.
Prof Archana Singal (Delhi, India)
Common Pediatric Nail Disorders
Dr Archana Singal (MD, FAMS) is a Director Professor in the department of Dermatology & STI, University College of Medical Sciences, New Delhi, India. She is also the Head of Dermatology, Faculty of Medical Sciences (FMS), University of Delhi and adjunct Professor at Kasturba Medical College, MAHE, Manipal (India).
She has been a teaching faculty for over 25 years. Her chief areas of interest include Nail disorders, Tropical dermatology and Genodermatoses. She has about 230 publications and has contributed more than 40 chapters related to Skin, STI and leprosy. She is the Founding President of the Nail Society of India (NSI). Established in 2012, NSI has 380 members and promotes knowledge on nail disorders in India through its annual National conference ONYCHOCON. She is editor of the biannual newsletter of NSI, ONYCHOSCOPE, that publishes recent updates, news and views from the world of Nail. She is the executive Board Member for International Nail Society. She is the chief editor of the first book on ONYCHOLOGY in India ‘Comprehensive approach to Nail disorders. She is also the chief editor for books ‘Comprehensive Approach to Infections in Dermatology’, ‘Atlas of Infections in Dermatology’ and ‘Superficial Dermatophytosis’.
Dr Mario Cutrone (Venice, Italy)
The Mouth of Newborns
Dr Karolina Gholam (London, UK)
Welcome & Introduction
Dr Lea Solman (London, UK)
Infantile Haemangiomas
Dr Natalia Cartledge (London, UK)
Bacterial & Viral Eruption
Dr Natalia Cartledge is a paediatrician working in paediatric dermatology at Great Ormond Street Hospital providing holistic patient centred care to children and young people with skin problems. She is also the lead for paediatric dermatology and allergy at Royal Surrey Foundation Trust where she established the dermatology service for children and young people. Her areas of expertise include atopic diseases, eczema and birth marks. She is an innovative dynamic consultant developing efficient front line services providing best care for children and young people. She has a passion for medical education and she regularly teaches medical students, junior doctors, nurses and primary care physicians
Dr Tess McPherson (Oxford, UK)
Overview of Atopic Eczema
Dr Tess McPherson MA MBBS MD FRCP is Consultant Dermatologist, Senior Clinical Lecturer & Clinical lead for paediatric and adolescent dermatology at Oxford University Hospitals (since 2012).
Dr McPhersons medical training included undergraduate medicine in Cambridge, international research working for the WHO in south America and an academic training post at the Weatherall Institute of Molecular Medicine (WIMM Oxford) studying immunology of eczema. This was followed by a paediatric dermatology training fellowship at Birmingham’s Children’s Hospital.
Dr McPherson was lead clinician on an NIHR funded project to develop a web resource for young adults with skin disease https://healthtalk.org/eczema/overview
In Oxford she has established an award winning dermatology service with psychological support for adolescents with skin conditions: Establishing and developing a Teenage and Young Adult dermatology clinic with embedded specialist psychological support.<https://onlinelibrary.wiley.com/doi/full/10.1111/ced.13950> Clin Exp Dermatol. 2019
Dr McPherson is Secretary (President elect) of the British Society of Paediatric Dermatology (BSPD). She is active in national and international paediatric dermatology including developing clinical guidelines and patient information for the British Association of Dermatology (BAD) monitoring effects of medications on children and young people (BADBIR registry) and work with charities and patient groups.
Dr Mary Glover (London, UK)
Vascular Malformations
Mary Glover is a consultant in Paediatric Dermatology at Great Ormond Street Hospital for Children. She trained in medicine at Cambridge University, and then in paediatrics, dermatology and paediatric dermatology in London. In recent years her clinical work has increasingly been focussed on vascular tumours, malformations and overgrowth.
She is ESPD treasurer, and on the ESPD training committee.
Dr Karolina Gholam (London, UK)
Genital rashes
Dr Paula Beattie (UK)
Dermatological Emergencies
Dr Paula Beattie is a Consultant Dermatologist and Honorary Senior Lecturer at the Royal Hospital for Children in Glasgow. She trained in Dermatology in Belfast and Dundee before Fellowships in Paediatric Dermatology at the Hospital for Sick Children, Toronto and Great Ormond Street Hospital, London. Paula has specialist interests in Eczema and vascular anomalies. She is actively involved in eczema teaching, guideline development and research including pharmaceutical trials of therapies for eczema in children and adults.
Dr Maanasa Polubothu (London, UK)
Overview of Birthmarks
Maanasa Polubothu MD PhD is an academic paediatric dermatologist, working in the Paediatric Dermatology department of Great Ormond Street Hospital for Children London. She trained in Medicine at Glasgow University, and in Paediatrics and Paediatric Dermatology in London. She undertook a laboratory research PhD in Molecular Genetics of paediatric dermatology diseases at University College London. She specialises in the clinical management and genetic investigation of complex high flow vascular anomalies, as well as other mosaic disorders.
Dr Karolina Gholam (London, UK)
Quiz
Dr Mauro Picardo (Rome, Italy)
Latest developments in Vitiligo
Mauro Picardo, is Director of the Cutaneous Physiopathology and Metabolomic Center at the San
Gallicano Dermatological Institute in Rome. He received his degree at the Rome University “La
Sapienza”. Scientific Director of the San Gallicano Institute from 2000-2006. The main topics of
interest are skin biochemistry, free radicals mediated damage of the skin, sebogenesis, mechanism
of control of skin pigmentation, depigmenting agents, vitiligo. He coordinates lipidomic studies on
acne and related disorders (seborrheic dermatitis, rosacea) in sebum and blood samples. The studies
leads to clarify mechanisms of control of lipidogenesis and to identify possible therapeutic targets.
His group has defined several collaborations with national and international research groups. He
served on several Boards of National and International Scientific Societies and Editorial Boards of
indexed scientific journals and member of the Italian National Health Council. Author of more than
300 publications in peer reviewed journals and of more than 30 chapters in multi authors books.
Mr Sebastian Walpole, MPhil (Brisbane, Australia)
BAP1 Tumour Predisposition Syndrome
Sebastian Walpole did his Master of Philosophy in the Oncogenomics group under Professor Nick Hayward at QIMR Berghofer Medical Research Institute in Brisbane, Australia. Sebastian did his undergraduate degree in science majoring in biomedical at the University of Queensland where he continued onto his honours with Prof Brian Gabrielli at the Translational Research Institute, looking at CHK1 inhibitors in melanoma. His master’s project was an investigation into BAP1 germline variants, and the related tumour predisposition syndrome and his subsequent work has been around the BAP1-TPDS. Sebastian commenced his MD at the University of Queensland in 2021.
Prof. Dr. Harald Kittler (Vienna, Austria)
Atypical Naevus Syndrome
Kittler Harald is an Ao. Professor at the Department of Dermatology, Medical University of Vienna. He leads a research team with a specific focus on in vivo skin imaging, dermatopathology, and machine learning. He has a clinical interest in skin cancer diagnosis, dermatoscopy, and dermatopathology. Dr. Kittler has been working for more than 20 years in the field of in vivo skin imaging and has published a number of scientific articles and books especially in the fields of dermatoscopy, in-vivo skin imaging, and computer assisted diagnosis of skin cancer.
Dr Carola Durán-McKinster (Mexico City, Mexico)
Greying Hair Syndromes
CAROLA DURÁN-McKINSTER, MD
Pediatric Dermatologist
Nationality: Mexican and American
Date of birth: 31 January 1953 in Mexico
Residence in Pediatrics and Pediatric Dermatology
National Institute of Pediatrics, Mexico city 1979-1982, 1982-1984
Mexican Board in Pediatric Dermatology.
1997 No. DP 12. Recertification 2017-2020
POSITION
HEAD OF THE DEPARTMENT OF PEDIATRIC DERMATOLOGY, 2002 to date
National Institute of Pediatrics of Mexico
PROFESSOR OF PEDIATRIC DERMATOLOGY
Universidad Nacional Autonoma de Mexico, 1989- 2020
MEMBER OF THE MEXICAN BOARD OF PEDIATRIC DERMATOLOGY
Since 2003 to date
RESEARCHER OF THE COMISSION FOR THE NATIONAL INSTITUTES OF HEALTH
National Board of Science and Technology
2001-2020
PUBLICATIONS: 123
CHAPTERS IN BOOKS: 40
BOOKS EDITOR: 6
THESIS: 14
CONFERENCES: NATIONAL AND INTERNATIONAL: 506
Dr Iwei Yeh (San Francisco, USA)
The Genetics of Spitz Naevi
I graduated from Harvard College in 1997 with a degree in Biochemical Sciences. Then I returned to my native Bay Area to attend medical school at Stanford University. I finished my studies at Stanford in 2006 with an MD and a PhD in Biomedical Informatics. I completed my dermatology residency at the University of Washington in Seattle, WA. During my residency I became interested in the genetics of melanocytic neoplasms and began a research path in the laboratory of Professor Boris Bastian. I completed my dermatopathology fellowship at UCSF in 2011. After a brief stint at Memorial Sloan Kettering Cancer Center, I returned to UCSF as a faculty member.
I currently practice diagnostic dermatopathology as well as basic and translational research in the field of melanocytic neoplasia. My work has been focused on uncovering the genetics and biology that underlies different types of melanocytic neoplasms, specifically Spitz tumors and acral and mucosal melanoma.
Prof Luc Thomas (Lyon, France)
Melanocytic nail disorders in children
Luc Thomas, MD, PhD, was board certified in dermatology in 1989 at Lyon 1 University. He was trained as a post-doctoral fellow at Harvard Medical School in 1990 and 1991, and obtained his PhD degree at Lyon 1 University in 1993. He became full professor of dermatology in 1996, first class professor in dermatology in 2009, outstanding class professor in dermatology in 2015, and chairman of the department of dermatology of Lyon 1 University – Centre Hospitalier Lyon Sud in 2003. He obtained his board certification in clinical oncology in 2013
His main research fields include skin oncology, early diagnosis of melanoma, dermoscopy, skin surgery and nail diseases. He has published more than 500 peer-reviewed scientific articles in international journals, is the co-editor of four books published in several languages and co-author of more than 25 books. He has lectured at many international meetings, is a member of the board of the International Dermoscopy Society, a past member of the board and treasurer of the French Society of Dermatology from 2000 to 2003, and treasurer of the World Congress of Dermatology in Paris in 2002.
Skin Tumours & Infiltrations
SESSION CHAIRS: PROF MARGARITA LARRALDE & DR ELENA POPE
SESSION SPEAKERS:
Prof Elena Pope (Toronto, Canada)
Lymphoma in Paediatric Dermatology
Dr. Elena Pope is a Professor in the Department of Paediatrics at the University of Toronto. In 2003, she became the Director of the Section of Dermatology, Division of Paediatric Medicine at the Hospital for Sick Children, Toronto, Ontario, Canada.
She received her medical training at The Institute of Medicine and Pharmacy, Bucharest Romania and the University of Toronto, and completed her training in Paediatrics and a fellowship in Pediatric Dermatology at the Hospital for Sick Children, Toronto.
Since becoming Director of Paediatric Dermatology, Dr. Pope has instituted innovative approaches to the care of paediatric dermatological conditions by establishing interdisciplinary clinics in Epidermolysis Bullosa, Cutaneous T-cell lymphoma, Vascular Tumor Clinic, Morphea and Genodermatoses.
She is a Project Investigator at the Research Institute, Hospital for Sick Children and is involved in numerous research projects stemming from her clinical interests focused on new interventions for rare and common pediatric dermatology conditions.
Dr. Pope has many teaching commitments at the Hospital for Sick Children and has been the recipient of the Department of Paediatrics’ Postgraduate Subspecialty Teaching Award.
Dr. Pope has held leadership positions in PeDRA (Pediatric Dermatology Research Alliance)- past chair of the grants committee, current chair of the communication committee and member of the PeDRA’s Executive Committee and Board of Directors.
Prof Margarita Larralde (Buenos Aires, Argentina)
Non-Vascular Tumours of Infancy
Margarita Larralde MD, PhD, is Full Professor of Dermatology at the University of Buenos Aires. She is the Head of the Division of Dermatology at the Department of Medicine in the German Hospital of Buenos Aires and the Chief of the Section Pediatric Dermatology at the Ramos Mejia Hospital of the Government of the City of Buenos Aires. She is also the Director of the Fellowships of Dermatology and Pediatric Dermatology in the University of Buenos Aires. She authored more than 200 manuscripts published in peer reviewed Dermatology Journals, was the editor of several books on Pediatric Dermatology and a lot of chapters of different Dermatology Books.
Dr Paula Luna (Buenos Aires, Argentina)
Dermatologic aspects of Langerhans Cell Histiocytosis
Paula C Luna, Dermatologist and pediatric dermatologist, Hospital Aleman, Buenos Aires, Argentina.
DIrector of the fellowship on psoriasis and inflammatory diseases, Hospital Aleman.
General Secretary of SDPL (sociedad de dermatologia pediatrica para latinoamerica) and SOARPSO (sociedad argentina de psoriasis).
Prof Christine Bodemer (Paris, France)
Mastocytosis
Prof. Dr Hab. Wojciech Baran (Wroclaw, Poland)
Molluscum Contagiosum – to treat or not to treat
Wojciech Baran is a member of ESPD since 2016. His interest in paediatric dermatology started in 2012 when he became the Head of Paediatric Dermatology Unit in the Department of Dermatology at Wroclaw Medical University. In 2021 he received full professor nomination from President of Polish Republic. His scientific point of interest includes psoriasis, atopic dermatitis and lupus erythematosus. Since 2002 he conducted more than 50 clinical trials in psoriasis vulgaris, atopic dermatitis, hand eczema, lupus, urticaria and hidradenitis suppurativa. He was trained in many dermatological centres i.e. Dortmund, Kiel, Aachen, München and received 10-months Otto Braun-Falco scholarship at Department of Dermatology in Dresden, Germany. He is a member of Polish Dermatological Society (PTD), European Academy of Dermatology and Venereology (EADV), International Society of Dermatology (ISD), European Society of Dermatological Research (ESDR) and European Society for Paediatric Dermatology (ESPD) Board Member since 2020. He started to educate polish dermatologists and paediatricians as a lecturer in paediatric dermatology since 2014 during many national conferences and since 2019 he organises national Child’s Skin Conference in Poland with over 500 participants from the whole country. This autumn third edition hopefully will take place in Wroclaw Convention Centre.
Dr Donna Marie Sarrosa (Manilla, Philippines)
Skin Lesions: What is it – a sign of a serious disease
DONNA MARIE LEELIN-SARROSA, MD, FPDS
Specialty: Fellow in Dermatology (FPDS)
Subspecialty: Pediatric Dermatology
Education
- S Biology, University of Santo Tomas,(UST) Philippines 1982-1986)
- Doctor of Medicine, UST(1986-1990)
Residency Training
Makati Medical Center (MMC), Department of Dermatology ( 1992-1994)
Post Graduate Training
- Jackson Memorial Hospital – University of Miami School of Medicine,
Miami Florida, USA (April 3,1995- June 30, 1995)
- National Skin Center, Singapore, Dermatology Fellowship ( Sept1,1995- November 30,1995)
- Hospital for Sick Children and University of Toronto, Toronto, Canada
Fellow in Pediatric Dermatology July 1,1996- June 30, 1997)
Board Examinations
- Diplomate in Dermatology , Philippine Dermatological Society (PDS)1996
AFFILIATIONS
- Philippine Dermatological Society – Fellow Member
- Society of Pediatric Dermatology, USA – Fellow Member
- American Academy of Dermatology, USA – Fellow Member
- Makati Medical Society- Councilor Officer 2021-2022
- Asian Society of Pediatric Dermatology –Board Director and Executive Committee (2021-2022)
Past Positions
- Assistant Chair, Continuing Medical Education Committee, PDS 2000-2001
- Scientific Committee, Head, PDS Annual Convention 2006-2007
- Member, Board of Examiners, PDS 2008-2009
- Co Chair, Scientific Committee, PDS Annual Convention 2008-2009
- Chair, Board of Examiners, PDS 2010-2011
- Chair, Regional Congress in Pediatric Dermatology in association with PDS, 2008
- Board of Directors, PDS 2004-2013 and Secretary PDS 2008-2009
- Head, Academics Committee and Subspecialties PDS 2010-2011
- Head, Outreach Committee and HIS program PDS 2012-2013
- Past Chair, Pediatric Dermatology Subspecialty Core Group, Philippine Dermatology Society (PDS) 2013 –2018
- Training Officer, Department of Dermatology, Makati Medical Center (MMC) 2014 – 2021
Present Position
- Vice Chairman and Executive Committee Member, Department of Dermatology, Makati Medical Center (MMC)
- Head, Pediatric Dermatology Section, Department of Dermatology, MMC
- Board Director and Executive Committee, Asian Society of Pediatric Dermatology
- Active Staff, St. Luke’s Global City, Department of Dermatology
- Active Staff, Makati Medical Center, Department of Dermatology
- Board Member, Derma 360, Rockwell Makati , Philippines
Dr Eulalia Baselga-Torres (Barcelona, Spain)
Emergencies in Vascular Malformations
Eulalia Baselga is currently the Head of Dermatology at the Hospital Sant Joan de Deu, Children’s Hospital . She coordinates a Vascular Clinic Unit. Dr. Baselga has authored over 160 articles in International journals and over 17 chapters in books. She is member of the Spanish Society for Paediatric Dermatology, American Academy of Dermatology, American Dermatologic Association, Society for Pediatric Dermatology, European Academy of Paediatric Dermatology, Sociedad Latinoamericana de Dermatologia Pediatrica. She is on the editorial board of Actas Dermo-Sifiligroficas, and Pediatric Dermatology. Her main areas of interest are hemangiomas, vascular lesions and atopic dermatitis.
Dr Dawn Siegel (Milwaukee, USA)
PHACE Beyond Infancy: What Do We Need to Watch?
Dr. Siegel is the Director of the PHACE Syndrome International Clinical Registry and Genetic Repository with a cohort of over 300 individuals with PHACE syndrome. Her research has focused on the understanding of the pathogenesis, neurovascular complications, and natural history of PHACE syndrome. In 2017, she was awarded a NIH Gabriella Miller Kids First X01 for whole genome sequencing of this cohort with infantile hemangiomas associated with multi-organ structural birth defects. Analysis of this WGS for structural changes with copy number variation studies is ongoing. For the past decade Dr. Siegel has been dedicated to supporting patient advocacy groups, including serving on the medical advisory boards for the Foundation for Ichthyosis and Related Skin Diseases, the Costello Syndrome Family Network and the PHACE Syndrome Community. Her current work is focused on addressing health disparities in pediatric dermatology. Dr. Siegel is founding member of the Pediatric Dermatology Research Alliance (PeDRA); and is immediate past Co-President of PeDRA. Her leadership roles at the Medical College of Wisconsin and Children’s Wisconsin include: Medical Director of the Vascular Anomaly Clinic, Co-Director of the Neurofibromatosis and RASopathy Center, Vice Chair of Research for the Department of Dermatology and Pediatric Dermatology Fellowship Director.
Dr Maanasa Polubothu (London, UK)
Update on Arteriovenous Malformations
Maanasa Polubothu MD PhD is an academic paediatric dermatologist, working in the Paediatric Dermatology department of Great Ormond Street Hospital for Children London. She trained in Medicine at Glasgow University, and in Paediatrics and Paediatric Dermatology in London. She undertook a laboratory research PhD in Molecular Genetics of paediatric dermatology diseases at University College London. She specialises in the clinical management and genetic investigation of complex high flow vascular anomalies, as well as other mosaic disorders.
Prof Rod Phillips (Melbourne, Australia)
Factors complicating hemangioma treatment with beta-blockers
Professor Roderic Phillips trained in paediatric dermatology at Great Ormond St Hospital, London. Over the past 25 years as a paediatric skin specialist at the Royal Children’s Hospital, Melbourne, one of his particular clinical interests has been in the field of vascular birthmarks and lesions. He is chairperson of the RCH Vascular Anomalies Committee. He is currently involved in several research projects aimed at improving outcomes in these children.
Dr Mary Glover (London, UK)
Generalised Lymphatic Anomaly
Mary Glover is a consultant in Paediatric Dermatology at Great Ormond Street Hospital for Children. She trained in medicine at Cambridge University, and then in paediatrics, dermatology and paediatric dermatology in London. In recent years her clinical work has increasingly been focussed on vascular tumours, malformations and overgrowth.
She is ESPD treasurer, and on the ESPD training committee.
Prof Ilona Frieden (San Francisco, USA)
Vascular stains: Moving beyond “nevus flammeus”, “port-wine stains”, and “capillary malformations”
Ilona Frieden, MD is Professor of Dermatology and Pediatrics at the University of California San Francisco where she helped to found the UCSF Birthmarks and Vascular anomalies clinic. She is a clinical and research expert in pediatric skin diseases, particularly infantile hemangiomas and other vascular anomalies. She has served in numerous leadership roles in Dermatology and Pediatric Dermatology. She is past editor of the journal Pediatric Dermatology and a co-editor of the textbook Neonatal and Infant Dermatology now in its 3rd edition. She is an author on more than 300 original articles and numerous book chapters.